Sansure Biotech Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 2,128

Employees

  • Stock Symbol
  • 688289

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $2.25
  • (As of Friday Closing)

Sansure Biotech General Information

Description

Sansure Biotech Inc is engaged in the Research, development, production, and sales of diagnostic reagents and instruments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 680, Lusong Road
  • Hi-Tech Development Zone
  • Changsha, Hunan 410205
  • China
+86 0731
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Laboratory Services (Healthcare)
Stock Exchange
SHG
Corporate Office
  • No. 680, Lusong Road
  • Hi-Tech Development Zone
  • Changsha, Hunan 410205
  • China
+86 0731

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sansure Biotech Stock Performance

As of 13-Nov-2026, Sansure Biotech’s stock price is $2.25. Its current market cap is $1.29B with 575M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.25 $2.31 $1.98 - $3.28 $1.29B 575M 5.27M $0.03

Sansure Biotech Financials Summary

As of 30-Sep-2026, Sansure Biotech has a trailing 12-month revenue of $239M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,103,446 1,163,867 1,260,515 946,040
Revenue 239,350 228,266 203,201 142,351
EBITDA 5,322 45,046 46,401 67,154
Net Income 16,200 27,664 38,408 51,410
Total Assets 1,431,149 1,361,596 1,178,586 1,192,648
Total Debt 224,585 161,121 57,924 5,405
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sansure Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sansure Biotech‘s full profile, request access.

Request a free trial

Sansure Biotech Patents

Sansure Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026153377-A1 Quantitative composition, kit, method and use Pending 17-Jan-2025
WO-2026130573-A1 Liquefying agent and use thereof, and nucleic acid detection system Pending 20-Dec-2024
EP-4783174-A1 Gene sequencing data analysis method and apparatus, computing device and readable storage medium Pending 29-Mar-2024
WO-2025200669-A1 Gene sequencing data analysis method and apparatus, computing device and readable storage medium Pending 29-Mar-2024
US-20260341417-A1 Gene sequencing data analysis method, computing device, and readable storage medium Pending 29-Mar-2024 G16B50/40
To view Sansure Biotech’s complete patent history, request access »

Sansure Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sansure Biotech Investments & Acquisitions (15)

Sansure Biotech’s most recent deal was a Later Stage VC with Zheyuan Technology for . The deal was made on 05-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zheyuan Technology 05-Aug-2026 Later Stage VC Decision/Risk Analysis
inno-train Diagnostik 29-Jan-2026 Merger/Acquisition Diagnostic Equipment
Hunan Sanway SepSMART 04-Sep-2025 Merger/Acquisition Laboratory Services (Healthcare)
GeneMind 27-May-2025 PE Growth/Expansion Diagnostic Equipment
ShengWeiKunTeng 08-May-2025 Early Stage VC Diagnostic Equipment
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Sansure Biotech ESG

Risk Overview

Risk Rating

Updated August, 31, 2024

28.45 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Healthcare

Industry

of 581

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Sansure Biotech’s complete esg history, request access »

Sansure Biotech Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Hunan Sanway SepSMART Changsha, China 2024
Hygene Biomedicine Zhongshan, China 2004
inno-train Diagnostik Kronberg, Germany 1998

Sansure Biotech FAQs

  • When was Sansure Biotech founded?

    Sansure Biotech was founded in 2008.

  • Where is Sansure Biotech headquartered?

    Sansure Biotech is headquartered in Changsha, China.

  • What is the size of Sansure Biotech?

    Sansure Biotech has 2,128 total employees.

  • What industry is Sansure Biotech in?

    Sansure Biotech’s primary industry is Biotechnology.

  • Is Sansure Biotech a private or public company?

    Sansure Biotech is a Public company.

  • What is Sansure Biotech’s stock symbol?

    The ticker symbol for Sansure Biotech is 688289.

  • What is the current stock price of Sansure Biotech?

    As of 13-Nov-2026 the stock price of Sansure Biotech is $2.25.

  • What is the current market cap of Sansure Biotech?

    The current market capitalization of Sansure Biotech is $1.29B.

  • What is Sansure Biotech’s current revenue?

    The trailing twelve month revenue for Sansure Biotech is $239M.

  • What is Sansure Biotech’s annual earnings per share (EPS)?

    Sansure Biotech’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process